Middle East & Africa Nicotinamide Adenine Dinucleotide (nad) Products Market Size & Outlook

The nicotinamide adenine dinucleotide (nad) products market in Middle East & Africa is expected to reach a projected revenue of US$ 513.2 million by 2033. A compound annual growth rate of 14.7% is expected of Middle East & Africa nicotinamide adenine dinucleotide (nad) products market from 2025 to 2033.
Revenue, 2024 (US$M)
$145.2
Forecast, 2033 (US$M)
$513.2
CAGR, 2025 - 2033
14.7%
Report Coverage
Middle East & Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Middle East & Africa nicotinamide adenine dinucleotide (nad) products market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

MEA nicotinamide adenine dinucleotide (nad) products market highlights

  • The MEA nicotinamide adenine dinucleotide (nad) products market generated a revenue of USD 145.2 million in 2024.
  • The market is expected to grow at a CAGR of 14.7% from 2025 to 2033.
  • In terms of segment, oral supplements was the largest revenue generating product in 2024.
  • Topical Products is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, UAE is expected to register the highest CAGR from 2025 to 2033.


MEA data book summary

Market revenue in 2024USD 145.2 million
Market revenue in 2033USD 513.2 million
Growth rate14.7% (CAGR from 2025 to 2033)
Largest segmentOral supplements
Fastest growing segmentTopical Products
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationOral Supplements, Topical Products, Others(NAD Injections, NAD IV, Nad Nasal Spray)


Other key industry trends

  • In terms of revenue, MEA region accounted for 4.2% of the global nicotinamide adenine dinucleotide (nad) products market in 2024.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 8,180.5 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Nicotinamide Adenine Dinucleotide (NAD) Products Market Companies

Name Profile # Employees HQ Website
HPN+ View profile 101-250 Gronau, Nordrhein-Westfalen, Germany, Europe https://hpnplus.de/
Wonderfeel Biosciences View profile 11-50 San Francisco, California, United States, North America https://www.getwonderfeel.com
Cata-Kor View profile 1-10 Wilmington, Delaware, United States, North America https://www.catakor.com
Elysium View profile 11-50 New York, New York, United States, North America http://www.elysiumhealth.com
Niagen Bioscience View profile 101-250 Los Angeles, California, United States, North America https://www.niagenbioscience.com/
Codeage LLC View profile - - -
Thorne Research Inc. View profile 251-500 New York, New York, United States, North America https://www.thorne.com
Nutricost View profile 101-250 Orem, Utah, United States, North America https://nutricost.com
Renue By Science View profile - Jacksonville, Florida, United States, North America https://renuebyscience.com/
Life Extension View profile 251-500 Fort Lauderdale, Florida, United States, North America https://www.lifeextension.com/

Middle East & Africa nicotinamide adenine dinucleotide (nad) products market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nicotinamide adenine dinucleotide (nad) products market will help companies and investors design strategic landscapes.


Oral supplements was the largest segment with a revenue share of 83.26% in 2024. Horizon Databook has segmented the Middle East & Africa nicotinamide adenine dinucleotide (nad) products market based on oral supplements, topical products, others(nad injections, nad iv, nad nasal spray) covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Middle East & Africa nicotinamide adenine dinucleotide (nad) products market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa nicotinamide adenine dinucleotide (nad) products market databook

  • Our clientele includes a mix of nicotinamide adenine dinucleotide (nad) products market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa nicotinamide adenine dinucleotide (nad) products market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa nicotinamide adenine dinucleotide (nad) products market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA nicotinamide adenine dinucleotide (nad) products market size, by country, 2021-2033 (US$M)

Middle East & Africa Nicotinamide Adenine Dinucleotide (NAD) Products Market Outlook Share, 2024 & 2033 (US$M)

MEA nicotinamide adenine dinucleotide (nad) products market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online